Evidence map›Paper›PMID 33369242›Full record

ArticleAdvanced healthcare materials2021

Discovery of a Novel Polymer for Xeno-Free, Long-Term Culture of Human Pluripotent Stem Cell Expansion.

Aishah Nasir, Jordan Thorpe, Laurence Burroughs, Joris Meurs, Sara Pijuan-Galito, Derek J Irvine, Morgan R Alexander, Chris Denning

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Advancements in theFrontiers in toxicology · 2025
    Review
  6. Article
  7. Review
  8. Vascularizing the brainiScience · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aishah NasirDivision of Cancer & Stem Cells, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-0500-9974
Jordan ThorpeDivision of Cancer & Stem Cells, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.
Laurence BurroughsSchool of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0003-0389-5148
Joris MeursSchool of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-0288-0422
Sara Pijuan-GalitoDivision of Cancer & Stem Cells, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0002-7398-9441
Derek J IrvineDepartment of Chemical and Environmental Engineering, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0003-1461-9851
Morgan R AlexanderSchool of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0001-5182-493X
Chris DenningDivision of Cancer & Stem Cells, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.ORCID 0000-0003-0802-8617

Funding

British Heart Foundation P47352/CRMBritish Heart Foundation PG/14/59/31000British Heart Foundation RG/14/1/30588British Heart Foundation RM/13/30157British Heart Foundation SP/15/9/31605National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013105/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/C013202/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/K000225/1Wellcome TrustWellcome Trust 201457/Z/16/Z
6 · The paper itself

Abstract

Human pluripotent stem cells (hPSCs) can be expanded and differentiated in vitro into almost any adult tissue cell type, and thus have great potential as a source for cell therapies with biomedical application. In this study, a fully-defined polymer synthetic substrate is identified for hPSC culture in completely defined, xenogenic (xeno)-free conditions. This system can overcome the cost, scalability, and reproducibility limitations of current hPSC culture strategies, and facilitate large-scale production. A high-throughput, multi-generational polymer microarray platform approach is used to test over 600 unique polymers and rapidly assess hPSC-polymer interactions in combination with the fully defined xeno-free medium, Essential 8 (E8). This study identifies a novel nanoscale phase separated blend of poly(tricyclodecane-dimethanol diacrylate) and poly(butyl acrylate) (2:1 v/v), which supports long-term expansion of hPSCs and can be readily coated onto standard cultureware. Analysis of cell-polymer interface interactions through mass spectrometry and integrin blocking studies provides novel mechanistic insight into the role of the E8 proteins in promoting integrin-mediated hPSC attachment and maintaining hPSC signaling, including ability to undergo multi-lineage differentiation. This study therefore identifies a novel substrate for long-term serial passaging of hPSCs in serum-free, commercial chemically-defined E8, which provides a promising and economic hPSC expansion platform for clinical-scale application.

Indexed as

Cell Culture TechniquesPluripotent Stem CellsCell DifferentiationCell ProliferationHumansPolymersReproducibility of ResultsPolymersbiomaterials discoveryEssential 8 mediumhuman pluripotent stem cellspolymer microarraysxeno-free conditions

Identifiers

PMID33369242
PMCPMC11469126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.